Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen, Inc. | -0.93% | 291.40 | 1.4% | $865.23m | |
| AMGN | Amgen, Inc. | 0.28% | 221.31 | 1.3% | $495.03m | |
| CELG | Celgene Corp. | 0.39% | 110.00 | 1.3% | $448.97m | |
| GILD | Gilead Sciences, Inc. | -0.50% | 64.32 | 1.0% | $384.61m | |
| ILMN | Illumina, Inc. | 0.25% | 295.73 | 3.5% | $305.32m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.97% | 203.86 | 1.9% | $290.09m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.20% | 348.41 | 2.6% | $262.04m | |
| EXAS | EXACT Sciences Corp. | -0.77% | 79.91 | 24.0% | $196.13m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.39% | 109.44 | 2.0% | $190.16m | |
| SGEN | Seattle Genetics, Inc. | 2.16% | 110.64 | 6.1% | $126.52m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.73% | 75.88 | 4.3% | $110.72m | |
| SRPT | Sarepta Therapeutics, Inc. | 5.46% | 99.95 | 14.6% | $106.88m | |
| A | Agilent Technologies, Inc. | 0.26% | 77.05 | 1.6% | $100.02m | |
| MRTX | Mirati Therapeutics, Inc. | 1.12% | 104.33 | 2.3% | $89.09m | |
| NBIX | Neurocrine Biosciences, Inc. | 0.50% | 111.40 | 5.0% | $84.24m |
Company Profile
Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170, and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.